Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
CNY 8.13
(0.62%)
CNY 8.13
(0.62%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 36 Million CNY | 59.17% |
| 2022 | 22.61 Million CNY | -88.38% |
| 2021 | 194.59 Million CNY | -34.46% |
| 2020 | 296.89 Million CNY | -41.84% |
| 2019 | 510.5 Million CNY | 23.31% |
| 2018 | 414 Million CNY | 42.76% |
| 2017 | 290 Million CNY | 1275.89% |
| 2016 | 21.07 Million CNY | -80.85% |
| 2015 | 110.05 Million CNY | -8.24% |
| 2014 | 119.93 Million CNY | 59.92% |
| 2013 | 75 Million CNY | 321.35% |
| 2012 | 17.8 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 25 Million CNY | -16.67% |
| 2008 | 30 Million CNY | -25.0% |
| 2007 | 40 Million CNY | -34.46% |
| 2006 | 61.03 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 27.28 Million CNY | -24.22% |
| 2024 Q3 | 14.9 Million CNY | -45.19% |
| 2024 Q2 | 27.44 Million CNY | 0.58% |
| 2023 Q4 | 36 Million CNY | 64.94% |
| 2023 Q2 | 10.96 Million CNY | -50.63% |
| 2023 Q1 | 22.2 Million CNY | -1.81% |
| 2023 FY | 36 Million CNY | 59.17% |
| 2023 Q3 | 21.82 Million CNY | 99.05% |
| 2022 Q2 | 79.77 Million CNY | -40.01% |
| 2022 Q1 | 132.97 Million CNY | -31.66% |
| 2022 FY | 22.61 Million CNY | -88.38% |
| 2022 Q4 | 22.61 Million CNY | -72.66% |
| 2022 Q3 | 82.72 Million CNY | 3.7% |
| 2021 FY | 194.59 Million CNY | -34.46% |
| 2021 Q3 | 180.86 Million CNY | -21.66% |
| 2021 Q2 | 230.86 Million CNY | -7.42% |
| 2021 Q4 | 194.59 Million CNY | 7.59% |
| 2021 Q1 | 249.36 Million CNY | -16.01% |
| 2020 Q1 | 436.5 Million CNY | -14.5% |
| 2020 Q3 | 296.1 Million CNY | -27.16% |
| 2020 Q4 | 296.89 Million CNY | 0.27% |
| 2020 FY | 296.89 Million CNY | -41.84% |
| 2020 Q2 | 406.5 Million CNY | -6.87% |
| 2019 Q2 | 583.55 Million CNY | -1.47% |
| 2019 Q4 | 510.5 Million CNY | -2.68% |
| 2019 FY | 510.5 Million CNY | 23.31% |
| 2019 Q1 | 592.27 Million CNY | 43.06% |
| 2019 Q3 | 524.55 Million CNY | -10.11% |
| 2018 Q1 | 319 Million CNY | 10.0% |
| 2018 FY | 414 Million CNY | 42.76% |
| 2018 Q2 | 317 Million CNY | -0.63% |
| 2018 Q3 | 365.5 Million CNY | 15.3% |
| 2018 Q4 | 414 Million CNY | 13.27% |
| 2017 Q1 | 41.09 Million CNY | 94.97% |
| 2017 Q4 | 290 Million CNY | -7.05% |
| 2017 FY | 290 Million CNY | 1275.89% |
| 2017 Q3 | 312 Million CNY | 246.67% |
| 2017 Q2 | 90 Million CNY | 119.01% |
| 2016 FY | 21.07 Million CNY | -80.85% |
| 2016 Q4 | 21.07 Million CNY | -30.1% |
| 2016 Q3 | 30.15 Million CNY | 0.32% |
| 2016 Q1 | 70.05 Million CNY | -36.34% |
| 2016 Q2 | 30.05 Million CNY | -57.09% |
| 2015 Q4 | 110.05 Million CNY | 266.89% |
| 2015 FY | 110.05 Million CNY | -8.24% |
| 2015 Q2 | 29.99 Million CNY | -62.47% |
| 2015 Q3 | 29.99 Million CNY | 0.0% |
| 2015 Q1 | 79.93 Million CNY | -33.35% |
| 2014 FY | 119.93 Million CNY | 59.92% |
| 2014 Q4 | 119.93 Million CNY | 215.63% |
| 2014 Q3 | 38 Million CNY | -44.12% |
| 2014 Q2 | 68 Million CNY | 0.0% |
| 2014 Q1 | 68 Million CNY | -9.33% |
| 2013 FY | 75 Million CNY | 321.35% |
| 2013 Q1 | 35 Million CNY | 96.63% |
| 2013 Q2 | 35 Million CNY | 0.0% |
| 2013 Q3 | 55 Million CNY | 57.14% |
| 2013 Q4 | 75 Million CNY | 36.36% |
| 2012 Q3 | 43.5 Million CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q4 | 17.8 Million CNY | -59.08% |
| 2012 FY | 17.8 Million CNY | 0.0% |
| 2012 Q2 | 43.5 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q1 | - CNY | -100.0% |
| 2009 Q4 | 25 Million CNY | 400.0% |
| 2009 FY | 25 Million CNY | -16.67% |
| 2009 Q2 | 25 Million CNY | 0.0% |
| 2009 Q3 | 5 Million CNY | -80.0% |
| 2008 Q4 | 30 Million CNY | 0.0% |
| 2008 FY | 30 Million CNY | -25.0% |
| 2007 FY | 40 Million CNY | -34.46% |
| 2006 FY | 61.03 Million CNY | 0.0% |